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Abstract
In this study, the trapping ability of the Gu¨nther Tulip and Celect inferior vena
cava filters was evaluated. Thrombus capture rates of the filters were tested in vitro
in horizontal position with thrombus diameters of 3 and 6 mm and tube diameter
of 19 mm. The filters were tested in centered and tilted positions. Sets of 30 clots
were injected into the model and the same process was repeated 20 times for each
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different condition simulated. Pressure drop experienced along the system was also
measured and the percentage of clots captured was recorded. The Gu¨nther Tulip
filter showed superiority in all cases, trapping almost 100% of 6 mm clots both in
an eccentric and tilted position and trapping 81.7% of the 3 mm clots in a centered
position and 69.3% in a maximum tilted position. The efficiency of all filters tested
decreased as the size of the embolus decreased and as the filter was tilted. The
injection of 6 clots raised the pressure drop to 4.1 mmHg, which is a reasonable
value that does not cause the obstruction of blood flow through the system.
Key words: Pulmonary embolism, inferior vena cava, Gu¨nther Tulip filter, Celect
fitler, clot capture rate, filter efficiency.
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1 Introduction1
Pulmonary embolism (PE) is a serious, potentially life-threatening condition. It is due to the blockage2
in a lung artery. The cause is usually a blood clot that dislodges from the deep veins in the lower3
extremities and travels to the lungs (Ren et al., 2012). Consequently, inferior vena cava (IVC) filters4
have been used to prevent recurrent PE in patients who are at very high risk, who are unresponsive5
to anticoagulation therapy, or in whom anticoagulation is contraindicated (Leask et al., 2004). IVC6
filters are used to intercept and trap large clots while allowing clot-free blood to pass freely towards7
the heart. As a result of the effort made to find the best filter device, there is a considerable number8
of filter devices in the market that are used in patients and tested by researchers.9
There are many numerical investigations and in vitro experiments that study the filter flow dynamics.10
Couch et al. (1997); Leask et al. (2001) have previously studied flow fields surrounding a vena cava filter11
using a noninvasive technique called photochromic. Furthermore, Singer et al. (2009) evaluated the12
flow hemodynamics of the TrapEase vena cava filter including simulated thrombi of multiple shapes,13
sizes, and trapping positions. Numerical studies on vena cava filters usually neglect the interaction14
between blood flow, the filter and the thrombi, but in order to evaluate the effectiveness of a filter and15
design new models, it is important to study other factors such as the clot capture efficiency.16
Clot capture efficiency has been quantified in in vitro studies, in which model clots are released into a17
mock circulation system, with the relative capture efficiency of various IVC filters analyzed statistically18
(Stewart et al., 2008). Hosaka et al. (1993) studied the DIL and the Greenfield vena cava filters’ clot-19
trapping ability in relation to the absolute diameter of the simulated vena cava before filter insertion20
and the clot size. Ferdani et al. (1995) tested six umbrella-type percutaneous inferior vena cava filters21
using a mock circulation device, for different flow rates and different filter positions. Lorch et al. (2002)22
evaluated 10 permanent and retrievable vena cava filters and compared them with the TrapEase filter.23
Katsamouris et al. (1988) tested six different filters and measured the pressure gradient across the24
filters. Other literature reports of in vitro studies analyzes the influence of the orientation of the IVC25
on clot capture efficiency, being an upright patient represented by a vertical configuration of the IVC26
whereas a supine patient is represented by a horizontal configuration. Lorch et al. (2002) observed27
that thrombus capture rates were significantly higher in the vertical position. Xian et al. (1995) went28
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a little further in their research and studied the influence of number of emboli on the trapping ability29
of the Greenfield, Vena Tech-LGM and Gu¨nther Tulip. It was observed that the proportion of trapped30
clots dropped with ascending clot rank and it was stated that the filter function deteriorates as the31
number of clots delivered increases.32
Most of the authors have done their research using filters such as Greenfield, DIL, Mobin-Uddin,33
Simon Ninitol, bird’s nest, Vena Tech-LGM filter or TrapEase filters, but there are few investigations34
(Lorch et al., 2002; Xian et al., 1995)in newer models like the Gu¨nther Tulip and Celect filters. For35
that reason, the aim of this in vitro study is to evaluate the clot capture efficiency of the Gu¨nther36
tulip and Celect filters, under different conditions and to prove, if possible, the superiority of one of37
the filters over the others.38
2 Materials and methods39
2.1 In vitro set-up40
Flexible and transparent polyvinyl chloride tubing of 19mm of inner diameter was used to simulate the41
vena cava. The model was fixed in the horizontal position and connected to two different reservoirs:42
A and B. From reservoir A the fluid circulated into the system in a stationary flow. Reservoir B was43
used to store the fluid from the system. As stated by Couch et al. (1997), the in vivo flow conditions44
of blood are approximately 2L/min so the flow rate was maintained at about 2L/min by adjusting45
the height of the outflow reservoir B. Reservoir A was continuously topped up in order to maintain a46
constant pressure and flow rate in the system (see Figure 1). Although some authors use a pulsatile47
flow for the experiments (Hosaka et al., 1993; Xian et al., 1995), a steady-state flow was used for these48
experiments since the blood flowing through veins barely carry any pulse because it is returning to49
the heart. The fluid used to simulate blood was comprised of 35% by volume of glycerol in water. The50
fluid was maintained at room temperature and had a density of 1.091g/cm3 and a dynamic viscosity51
of 0.0036 Pa.s, which is very approximate to blood dynamic viscosity (0.0035 Pa.s). The fluid used was52
Newtonian with a Reynolds number of 674. Blood is known to behave in a non-Newtonian fashion but53
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in a vessel of this diameter these effects will not be significant (Couch et al., 1997). Some authors such54
as Leask et al. (2004, 2001); Singer et al. (2009); Harlal et al. (2007); Neuerburg et al. (1993); Korbin55
et al. (1994) have also used a flow rate of 2L/min for IVC studies and utilized a Reynolds number of56
about 600. The reason why our Reynolds number is a bit higher is mainly because the fluid properties57
are slightly different and the diameter of the tubing used is also different.58
To ensure that the flow entering the filter was laminar and fully developed, the flow phantom tube was59
constructed with an entrance length of 137 cm. This corresponded to 7 tube diameters and ensured a60
parabolic velocity profile under the flow conditions used in these experiments.61
Three different filters were used to study their efficiency. Firt, a simple,modified Gu¨nter Tulip, not62
commercial filter was used. This filter is only used for mechanical testing in the lab. The Celect IVC63
filter and the Gu¨nter Tulip filter were also used. See Figure 2 for details on the filters used.64
2.2 Preparation of the clots65
The simulated clots were prepared from 200 mL of water and 10 gr of Agar. The blood clots were66
modelled as spheres for these experiments. Although the shape of the clots varies widely and have67
been approximated by different shapes in various works (Couch et al., 1997; Stewart et al., 2008;68
Robinson et al., 2013), no single shape can be rigorously assigned to a clot due to the inherently69
complex and random nature of its formation. Hence, a sphere not only alleviates the problem of70
various orientations of clots upon entry into the IVC, but also can be thought of as an averaged71
shape/orientation (Swaminathan et al., 2006).72
The clots used for the experiment are divided in two different categories: small clots and large clots,73
as it is seen in Figure 3. Small clots range from 8.2mm3 to 33.51mm3 (2.5 mm to 4 mm diameter74
clots), and large clots range from 65.45mm3 to 220.9mm3. 1200 clots of each of the two categories75
have been analyzed and used to study its size distribution. Image J (National Institutes of Health,76
Bethesda, Md) has been used to process the images and measure the particles sizes.77
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2.3 Testing procedures78
The filters were placed in the middle of the simulated IVC in a horizontal position. The filters were79
assessed in two different positions: central and eccentric. The eccentric position wanted to represent80
placement errors or migration of the filter, since sometimes the filter moves from its central position81
after it is released inside the vena. The eccentric position was set with the main axis of the filter placed82
at the maximum angle possible relative to the IVC.83
Clot trapping capacity was assessed by placing clots of various sizes into the flow system and counting84
the number of clots trapped passing through the filter. For each filter, 30 clots of each size were85
introduced at once. The trapped clots were removed between observations and the number of clots86
that passed through were recorded. This process was repeated 20 times for each filter and each size of87
clots, with the filter positioned centered. Furthermore, the Gu¨nther Tulip filter and the Celect filter88
were also positioned in a tilted position, and the same process was repeated 20 times for each clot size89
and each filter. The experiment was repeated a total of 200 times, and a total of 6000 clots were used.90
Pressure drop of the system was also measured using a traceable manometer in order to observe91
the effects of the clots in the pressure equilibrium of the system. The pressure was measured at two92
different points of the system in order to obtain the pressure drop. The first point was positioned 9093
cm upstream from the filter, and the second point was 10 cm downstream from the filter.94
Student’s t-test for independent samples was used to evaluate differences between filtration capacities95
of each filter.96
2.4 Numerical validation97
Two numerical simulations were carried out to validate the pressure drop measurements taken in vitro.98
Two different geometries were modelled. First, an idealized IVC with a filter inside of the vena and then,99
a IVC with the filter and 8 thrombi attached to it. Since the pressure drop experienced using different100
models of filters did not vary, only the (Gu¨nther Tulip) was used for both simulations. Computational101
meshes were created using Ansys Icem (Ansys Inc. Software, Canonsburg, PA, USA) and the numerical102
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CFD simulations were carried out using Ansys CFX (Ansys Inc. Software, Canonsburg, PA, USA).103
See Figure 4 for details on the numerical simulation.104
3 Results105
3.1 Particle size distribution106
Descriptive Statistics have been used to present a quantitative description of the main features of the107
data set (see Table 1). When analyzing the size distribution of small clots (Figure 3 b), the mean,108
median and mode are equal to 3.2 mm. The three values are the same and coincide with the peak of109
the histogram of Figure 3 b, which means that the data follow a normal distribution. The standard110
deviation is 0.26, which indicates that the data are concentrated around the mean and that the111
diameter is less variable. The histogram for small clots is bell-shaped, following a normal distribution,112
in agreement with the observations made from the central tendency values recorded. The histogram is113
symmetrical, the same amount of data falls on both sides of the mean and has skewness (the measure114
of the asymmetry of a histogram) of 0. The histogram has a tall and narrow shape as a consequence115
of the low standard deviation.116
The results of the analysis for large clots are a little bit different. The mean and median are equal117
to 6.4, but the mode has a greater value of 6.9. The histogram is not as symmetric as for small clots118
but it still follows a tendency similar to a normal distribution, as it is observed in Figure 3 c. The119
standard deviation for large clots is 0.5 which is larger to the one obtained for small clots. The data120
is more spread out around the mean and the histogram has a wider shape, as a consequence of the121
higher standard deviation.122
3.2 Filtering efficiency. Clot-Trapping Capacity123
The modified Gu¨nther Tulip filter had the lowest clot capture efficiency, as it may be expected (Table124
2 and Figure 5a and b). The results show that this filter cannot be used to prevent PE because there125
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is a huge percentage of thrombi (almost 80% of big clots and 94.5% of small clots) that pass through126
the filter, meaning that pulmonary embolism is more likely to occur if this filter is used.127
The most effective filter was the Gu¨nther Tulip filter in all cases, as shown in Table 2. For large clots,128
its effectiveness is almost 100% and it is barely reduced when the filter is set in a tilted position. For129
smaller clots, its effectiveness is reduced by about 11% when the filter is tilted. Filter 3 also shows130
good results when trapping large clots but its effectiveness trapping small clots is not as good and is131
reduced by 20% when the filter is tilted.132
Statistical evaluation was performed using Student’s t-test (see Table 2) to evaluate differences between133
filtration capacities (α ≤ 0.05). The results showed that the filtering efficiency of both Gu¨nther Tulip134
and Celect filters over the modified Gu¨nther Tulip were higher (p < 0.001). No significant statistical135
differences were observed between the Gu¨nther Tulip and Celect filters when small and large clots136
were inserted in the system in an eccentric position. On the other hand, when small clots were used137
in a tilted position, it was demonstrated that the Gu¨nther Tulip filter is significantly more efficient138
than the Celect filter (p = 0.01).139
All filters showed higher capture rates for large thrombi compared with small thrombi. Differences140
were more significant when the filters were tilted since the effectiveness of the device for large clots141
remained constant while it was reduced for smaller clots. Overall, looking at the results, the most142
efficient filter in terms of clot trapping ability seems to be the Gu¨nther Tulip and less efficient filter143
seems to be the modified Gu¨nther Tulip.144
It is observed in Figures 5 that the effect of gravity, as it will be discussed later in this paper, affects145
the results. The modified Gu¨nther Tulip is only able to trap clots that pass exactly through the center146
of the IVC while the clots flowing closer to the wall of the IVC passed more easily since the filter147
does not have secondary struts. When smaller clots are injected in the model, the effectiveness of the148
filter decreases considerably, being able to trap a smaller number of clots. Figure 5 shows the results149
obtained for the three filter models when large and small clots are injected in the model, being the150
filter set in a centered position. It is observed that the efficiency of both filters is excellent thanks151
to the secondary legs. The secondary struts help the filter trap the clots that do not travel directly152
through the center of the model. When small clots are thrown in the model, Figure 5 and Table 2153
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show that the efficiency of all the filters decreases. Most of the clots travelling through the center of154
the model are still trapped but some of them pass more easily through the struts.155
Figure 6 shows the results obtained for the Gu¨nther Tulip and the Celect filters when the filter is156
tilted. If Figure 5 and 6 are compared it can be observed that the volume of large clots captured by157
the filters does not vary. On the other hand, Figure 6c and d and Table 2 show that the efficiency158
of the filters decreases, when small clots are used. 6 mm clots are big enough to not affect the filter159
efficiency when it is tilted meanwhile 3 mm clots that travel directly away from the dependent wall of160
the IVC pass more easily.161
In conclusion, the efficiency of all filters tested decreased as the size of the embolus decreased and as162
the filter is tilted, as it could be expected. The Gu¨nther Tulip filter resulted as the most efficient filter.163
164
3.3 Pressures165
The pressure drop barely changed when the filter was inserted with respect to the measurements taken166
with no filter in the system. For both tests there was always a slight increase in pressure upstream.167
Higher pressures were recorded when some clots (6-8) were present in the filter. Subsequently, the effect168
of trapped clots on pressure drop was measured by injecting sequentially 8 clots and recording the169
pressure drop. 6 clots were needed to be trapped before a comparable increase of the pressure occurred.170
All the measurements were repeated 6 times to make sure that the recordings were consistent with each171
other, and the averaged values were reported in Table 3. Prior to injection of clots, the pressure drop172
was almost the same for the model with and without the filter inside. This shows that the presence of173
the filter in the model does not essentially vary the pressure gradient. Besides, as stated by Rahbar174
et al. (2011) and as shown by Leask et al. (2004, 2001); Harlal et al. (2007), the disturbances caused175
by the filters at a Reynolds number of 600 are negligible. The injection of 8 clots raised the pressure176
drop to 4.1 mmHg.177
The pressure drop was also measured using a flow rate of 3 L/min. Table 3 shows that the increase178
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in the flow rate increases considerably the pressure drop between the two points. A lot of studies179
on inferior vena cava filters use a flowrate of 2L/min (Katsamouris et al., 1988; Neuerburg et al.,180
1993; Korbin et al., 1994; Qian et al., 1994) but the reason why a flow rate of 3L/min has also been181
used is to compare the pressure drops obtained for two different flow rates, and to double check the182
pressure drop measurements. Besides, there is an increase in the flow rate of the IVC after Valsava183
manuever (Gindea et al., 1990; Eichenberger et al., 1995),so by using a 3L/min flowrate the behaviour184
of the filter in more adverse conditions is represented. All pressure readings in Table 3 are expressed185
in mmHg. The same procedures were repeated for both the Gu¨nther Tulip and the Celect filters and186
similar results were observed, which means that both filter have the same effect in pressure.187
The results obtained in the numerical simulations are in accordance with the in-vitro measurements.188
For the model with the Gu¨nther Tulip filter the pressure drop recorded was 0.5mmHg, which is similar189
to the in-vitro results of 0.6mmHg. For the second model, where 8 thrombi are attached to the filter,190
the pressure drop obtained was 4mmHg, meanwhile the pressure drop measured in vitro was 4mmHg.191
Figure 7 shows the pressure experienced along the model in a plane. It is observed how little the filter192
affects the pressure in the system meanwhile the thrombi cause a sudden decrease in the pressure.193
4 Discussion194
Clot capture rates in our experiment went from 5.5% to 99.5%. It was observed, in general, that the195
efficiency of the filter was reduced when the size of clots was reduced and when the position of the196
filter was tilted. The best-ranked filter is the Gu¨nther Tulip filter,.197
If the results from our experiment are compared to previous work (Ferdani et al., 1995; Katsamouris198
et al., 1988; Hammer et al., 1994), the Gu¨nther Tulip and Celect filters performed fairly well. In Kat-199
samouris et al. (1988) investigations, 3 filters (Movin-Udin, Amplatz and Gu¨nther basket) presented200
an increase in pressure above 20cmH2O (≃ 15mmHg) when 3 clots were trapped meanwhile the other201
3 filter models (Simon Nitinol, Kimray-Greemfield and bird’s nest) presented a pressure increase of202
almost 5cmH2O(≃ 3.7mmHg) when 6 clots were trapped (which is very close to our results). The203
main reason of the differences in the pressure drops between filter models is that some of them are204
10
designed for high clot-trapping capacity, and for that reason they impede flow the most and result205
in adverse flow conditions (Katsamouris et al., 1988). Ferdani et al. (1995) studied the difference in206
pressure by 6 vena cava filters and obtained similar results to our investigations, which show that the207
filters used by them have similar performance in terms of flow impedance. If the IVC is collapsed or208
close to being collapsed, due to a big amount of clots trapped around the filter, there is a huge increase209
in pressure inside the vena. Hirsch and Hoak (1996) state that the risk of thrombosis is elevated when210
the obstruction of the vena cava occurs. For that reason, if the filter causes obstruction of the vena211
cava, thrombosis is more likely to occur. Furthermore, Leask et al. (2004) also stated that successful212
treatment of thrombosis requires the filter to provide high filter efficiency without impeding the blood213
flow, in order to prevent from thrombosis. To conclude, the filters that result in a great increase of214
pressure after clot entrapment, will have the highest potential for IVC thrombosis.215
In vitro models have limitations that may raise questions about the clinical relevance of experimental216
studies. The tubing used in our model to represent the IVC was rigid. The deformations of the IVC217
were not taken into account, but respiratory variation and Valsalva result in profound changes in the218
diameter of the IVC (Murphy et al., 2008). Different results may be obtained if these deformations219
are considered.220
A second model limitation was the effect of gravity on flowing blood clots, and the influence of this221
effect on clot-trapping capacity of each filter. As blood flow velocity is highest in the center of the222
IVC, emboli are believed to be carried along the center of the blood stream (Qian et al., 1994). As223
shown by Lorch et al. (2002); Katsamouris et al. (1988); Robinson et al. (2013), clot capture rates were224
significantly higher with the device in the vertical position. In this report, tests were only performed225
in a stable horizontal position similar to that in supine patients. As a result of gravity, clots failed to226
remain in the center of the fluid column in the phantom and sometimes had a tendency to flow along227
the dependent wall of the IVC and passed more easily through the filter struts. So the effect of gravity228
decreases the clot capture rates when the experiment is performed in the horizontal position.229
When testing the filter in a tilted position, the devices were pushed into as much tilt as the model230
would allow so the effect of the tilt in the effectiveness of the filter was studied in a worst scenario231
case. When looking at the results obtained with the filters in a tilted position, this considerations has232
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to be taken into account.233
The clot size which leads to clinically significant pulmonary embolism remains unclear and dependent234
on factors such as former pulmonary embolization and pre-existing lung disease (Lorch et al., 2002).235
The sizes used for this experiment are similar to the diameters used by Lorch et al. (2002); Katsamouris236
et al. (1988); Xian et al. (1995). In our opinion, in cases where only capture of large emboli is necessary,237
such as in young patients with a healthy lung, the Celect filter can be recommended. On the other238
hand, if PE has to be prevented in patients with impaired pulmonary function or in a poor general239
condition who may not be able to tolerate even small emboli, the insertion of a more efficient filter240
such as the Gu¨nther Tulip could be recommended.241
An IVC filter cannot be chosen only on the basis of this experiment. Other factors such as ease242
of placement and documented clinical results must be taken into account. In vitro models are an243
important tool to evaluate the characteristics and performance of different filter models but they are244
limited and cannot reflect filter performances under the in vivo conditions in all aspects. However, in245
vitro testing help us to eliminate the most deficient models and understand how filters work inside the246
body. We realize that the method used to evaluate the efficiency of the filter simulates the worst case247
scenario leading to vena cava occlusion when using large clots. There are many different possibilities248
that can be studied when studying filtering efficiency, but we considered that studying the worst case249
scenario could be a good option to evaluate the efficiency of filters.250
To obtain clinically relevant results a more complex model should be done. Our model is a simplified251
in vitro IVC model, but we can observe the efficiency of the filter models used, being the Gu¨nther252
Tulip the most efficient of them. We can also conclude that the pressure through the system only253
increases significantly for the Celect and Gu¨nther Tulip when most of the space inside the vena is254
collapsed by clots. Neuerburg et al. (1993) studied the performance of the Gu¨nther Tulip in vivo. It255
was observed that the filter showed a good hemodynamic behavior in the flow circuit. Besides, the in256
vivo fatigue testing of the filter revealed a high mechanical testing and the filter demonstrated a good257
biocompatibility with complete endothelization of the wires being in contact with the caval wall. This258
in vivo finding along with our in vitro results demonstrate that the Gu¨nther Tulip is very good option259
to be used in patients.260
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Clinical observation studies as the ones performed by Neuerburg et al. (1993); Ferris et al. (1993);261
Athanasoulis et al. (2000) together with valid in vitro investigations are important steps on the way to262
design an ideal vena cava filter. Clinical observations reveal important aspects about the filters such263
as penetration of the wall, migration of the filter, and ease of placement but in vitro models allow to264
do very complete studies on filter efficiency.265
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(a) (b)
Fig. 1. Experimental set up: 1. Top-up, 2. Reservoir A, 3. Pressure tabs , 4. Traceable manometer,
5.IVC system, 8. Video recorder, 7. Reservoir B
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(a) (b) (c)
Fig. 2. IVC filters used for the experiment: (a) Modified Gu¨nther Tulip filter, (b) Gu¨nther Tulip filter,
(c) Celect filter. They are low profile, asymmetric, retrievable, made of a cobalt-chromium alloy filters
Cook (2014) that are manufactured by Cook Medical (Bloomington, IN). The design of the Celect
follows that of the Gu¨nther Tulip filter. Both of them have a half-basket shape with a length of 45
mm and a maximum diameter of 30 mm Cook (2014) and have a retrieval hook at the appex to allow
percutaneous retrieval or repositioning De Gregorio et al. (2003).
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Fig. 3. (a) Clots prepared for the experiment. left: small clots range from 65.45mm3 to 220.9mm3
(2.5 mm to 4 mm diameter clots), right: large clots range from 8.2mm3 to 33.51mm3 (5
mm to 7.5 mm diameter clots). (b) frequency histograms of the sample clots, used to estimate
the probability distribution of the feret’s diameter variable
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(a) (b)
Fig. 4. Finite element mesh of the Gu¨nther Tulip filter (a) without thrombi and (b) with some thrombi.
The two different geometrical models were built using the commercial software SolidWorks (Dessault,
SolidWorks Corp., France). Then, Ansys Icem (Ansys Inc. Software, Canonsburg, PA, USA) was used
to obtain the numerical grids. In order to guarantee that the numerical results were grid independent,
a mesh independence study was carried out prior to the presented simulations. Velocity profiles at
different locations of the IVC model were compared for different grid sizes, concluding that meshes
finer than 4 ∗ 106 for the model with the clots and 1 ∗ 106 for the model with the filter increased the
computational time without adding precision to the solution. The fluid grids were imported in the
commercial package Ansys CFX (Ansys Inc. Software, Canonsburg, PA, USA) were the fluid dynamics
computations were carried out. The numerical approach used by this software is extensively explained
in literature and given in details in CFX (2012). The fluid was assumed Newtonian, incompressible
under steady conditions, laminar and had the same density and viscosity that was used in the exper-
imental study. As boundary conditions, a steady parabolic flow profile with a total volume flow rate
of 2L/min was imposed at both inlet and outlet of the IVC to match the experimental set-up and
no-slip boundary conditions were applied at the wall, filter and clots. The convergence tolerance for
both models was set to 10−8, and the number of iterations was set to 500.
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(a) Modified Gu¨nther Tulip with
large clots trapped
(b) Modified Gu¨nther Tulip with
small clots trapped
(c) Gu¨nther Tulip with large clots (d) Celect with large clots
(e) Gu¨nther Tulip with small clots (f) Celect with small clots
Fig. 5. Small and large clots trapped by the modified Gu¨nther Tulip, Gu¨nther Tulip and Celect filters
21
(a) Gu¨nther Tulip with large clots (b) Celect with large clots
(c) Gu¨nther Tulip with small clots (d) Celect with small clots
Fig. 6. Small and large clots trapped by the Gu¨nther Tulip and Celect filters in a tilted postion
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(a) (b)
Fig. 7. Pressure along the numerical model
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small clots large clots
Mean 3.2 6.4
Mode 3.2 6.9
Median 3.2 6.4
STD 0.26 0.5
Clots used 1200 1200
Min.size (mm) 2.5 5
Max.size (mm) 4 7.5
Table 1
Descriptive analysis for clot samples. Measures of central tendency (mean, median, mode) and mea-
sures of variability of dispersion (standard deviation, maximum, minimum)
24
Filter Centered position Tilted position
small clots large clots small clots large clots
Modified Gu¨nther Tulip 5.5 21.2 - -
Gu¨nther Tulip 81.7∗ 99.5∗ 69.3† 99
Celect 78.5∗ 98.8∗ 57.8 99.3
Table 2
Percentage of clots (%) captured by each filter in a centered and tilted position. (∗ P<0.001 using
t-test, when compared with Filter 1 and † P<0.01 using t-test, when compared with Celect filter)
25
Filter without filter with filter (2L/min) with 6 clots (3L/min) with 6 clots
Gu¨nther Tulip 0.6 0.6 6.4 4.1
Celect 0.6 0.6 6.4 4.2
Table 3
Measured pressure drop experienced by 2 vena cava filters (mm Hg)
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Abstract
In this study, the trapping ability of the Gu¨nther Tulip and Celect inferior vena
cava filters was evaluated. Thrombus capture rates of the filters were tested in vitro
in horizontal position with thrombus diameters of 3 and 6 mm and tube diameter
of 19 mm. The filters were tested in centered and tilted positions. Sets of 30 clots
were injected into the model and the same process was repeated 20 times for each
review_paper_with highlighting.tex
Click here to view linked References
different condition simulated. Pressure drop experienced along the system was also
measured and the percentage of clots captured was recorded. The Gu¨nther Tulip
filter showed superiority in all cases, trapping almost 100% of 6 mm clots both in
an eccentric and tilted position and trapping 81.7% of the 3 mm clots in a
centered position and 69.3% in a maximum tilted position. The efficiency
of all filters tested decreased as the size of the embolus decreased and as the filter
was tilted. The injection of 6 clots raised the pressure drop to 4.1 mmHg, which is
a reasonable value that does not cause the obstruction of blood flow through the
system.
Key words: Pulmonary embolism, inferior vena cava, Gu¨nther Tulip filter, Celect
fitler, clot capture rate, filter efficiency.
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1 Introduction1
Pulmonary embolism (PE) is a serious, potentially life-threatening condition. It is due to the blockage2
in a lung artery. The cause is usually a blood clot that dislodges from the deep veins in the lower3
extremities and travels to the lungs Ren et al. (2012). Consequently, inferior vena cava (IVC) filters4
have been used to prevent recurrent PE in patients who are at very high risk, who are unresponsive5
to anticoagulation therapy, or in whom anticoagulation is contraindicated Leask et al. (2004). IVC6
filters are used to intercept and trap large clots while allowing clot-free blood to pass freely towards7
the heart. As a result of the effort made to find the best filter device, there is a considerable number8
of filter devices in the market that are used in patients and tested by researchers.9
There are many numerical investigations and in vitro experiments that study the filter flow dynamics.10
Couch et al. (1997) and Leask et al. (2001) have previously studied flow fields surrounding a vena cava11
filter using a noninvasive technique called photochromic. Furthermore, Singer et al. (2009) evaluated12
the flow hemodynamics of the TrapEase vena cava filter including simulated thrombi of multiple shapes,13
sizes, and trapping positions. Numerical studies on vena cava filters usually neglect the interaction14
between blood flow, the filter and the thrombi, but in order to evaluate the effectiveness of a filter and15
design new models, it is important to study other factors such as the clot capture efficiency.16
Clot capture efficiency has been quantified in in vitro studies, in which model clots are released17
into a mock circulation system, with the relative capture efficiency of various IVC filters analyzed18
statistically Stewart et al. (2008). Hosaka et al. (1993) studied the DIL and the Greenfield vena cava19
filters’ clot-trapping ability in relation to the absolute diameter of the simulated vena cava before filter20
insertion and the clot size. Ferdani et al. (1995) tested six umbrella-type percutaneous inferior vena21
cava filters using a mock circulation device, for different flow rates and different filter positions. Lorch22
et al. (2002) evaluated 10 permanent and retrievable vena cava filters and compared them with the23
TrapEase filter. Katsamouris et al. (1988) tested six different filters and measured the pressure gradient24
across the filters. Other literature reports of in vitro studies analyzes the influence of the25
orientation of the IVC on clot capture efficiency, being an upright patient represented by26
a vertical configuration of the IVC whereas a supine patient is represented by a horizontal27
configuration. Lorch et al. (2002) observed that thrombus capture rates were significantly higher in28
3
the vertical position. Xian et al. (1995) went a little further in their research and studied the influence29
of number of emboli on the trapping ability of the Greenfield, Vena Tech-LGM and Gu¨nther30
Tulip. It was observed that the proportion of trapped clots dropped with ascending clot rank and it31
was stated that the filter function deteriorates as the number of clots delivered increases.32
Most of the authors have done their research using filters such as Greenfield, DIL, Mobin-Uddin,33
Simon Ninitol, bird’s nest, Vena Tech-LGM filter or TrapEase filters, but there are few investigations34
Lorch et al. (2002); Xian et al. (1995)in newer models like the Gu¨nther Tulip and Celect filters.35
For that reason, the aim of this in vitro study is to evaluate the clot capture efficiency of the Gu¨nther36
tulip and Celect filters, under different conditions and to prove, if possible, the superiority of one of37
the filters over the others.38
2 Materials and methods39
2.1 In vitro set-up40
Flexible and transparent polyvinyl chloride tubing of 19mm of inner diameter was used to simulate the41
vena cava. The model was fixed in the horizontal position and connected to two different reservoirs: A42
and B. From reservoir A the fluid circulated into the system in a stationary flow. Reservoir B was used43
to store the fluid from the system. As stated by Couch et al. (1997), the in vivo flow conditions of blood44
are approximately 2L/min so the flow rate was maintained at about 2L/min by adjusting the height45
of the outflow reservoir B. Reservoir A was continuously topped up in order to maintain a constant46
pressure and flow rate in the system (see Figure 1). Although some authors use a pulsatile flow for47
the experiments Hosaka et al. (1993); Xian et al. (1995), a steady-state flow was used for these48
experiments since the blood flowing through veins barely carry any pulse because it is returning to49
the heart. The fluid used to simulate blood was comprised of 35% by volume of glycerol in water. The50
fluid was maintained at room temperature and had a density of 1.091g/cm3 and a dynamic viscosity51
of 0.0036 Pa.s, which is very approximate to blood dynamic viscosity (0.0035 Pa.s). The fluid used was52
Newtonian with a Reynolds number of 674. Blood is known to behave in a non-Newtonian fashion but53
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in a vessel of this diameter these effects will not be significant Couch et al. (1997). Some authors54
such as Leask et al. (2004, 2001); Singer et al. (2009); Harlal et al. (2007); Neuerburg55
et al. (1993); Korbin et al. (1994) have also used a flow rate of 2L/min for IVC studies56
and utilized a Reynolds number of about 600. The reason why our Reynolds number is57
a bit higher is mainly because the fluid properties are slightly different and the diameter58
of the tubing used is also different.59
To ensure that the flow entering the filter was laminar and fully developed, the flow phantom tube was60
constructed with an entrance length of 137 cm. This corresponded to 7 tube diameters and ensured a61
parabolic velocity profile under the flow conditions used in these experiments.62
Three different filters were used to study their efficiency. Firt, a simple,modified Gu¨nter Tulip, not63
commercial filter was used. This filter is only used for mechanical testing in the lab. The Celect IVC64
filter and the Gu¨nter Tulip filter were also used. See Figure 2 for details on the filters used.65
2.2 Preparation of the clots66
The simulated clots were prepared from 200 mL of water and 10 gr of Agar. The blood clots were67
modelled as spheres for these experiments. Although the shape of the clots varies widely and have68
been approximated by different shapes in various works Couch et al. (1997); Stewart et al. (2008);69
Robinson et al. (2013), no single shape can be rigorously assigned to a clot due to the inherently70
complex and random nature of its formation. Hence, a sphere not only alleviates the problem of71
various orientations of clots upon entry into the IVC, but also can be thought of as an averaged72
shape/orientation Swaminathan et al. (2006).73
The clots used for the experiment are divided in two different categories: small clots and large clots, as74
it is seen in Figure 3. Small clots range from 8.2mm3 to 33.51mm3 (2.5 mm to 4 mm diameter75
clots), and large clots range from 65.45mm3 to 220.9mm3. 1200 clots of each of the two categories76
have been analyzed and used to study its size distribution. Image J (National Institutes of Health,77
Bethesda, Md) has been used to process the images and measure the particles sizes.78
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2.3 Testing procedures79
The filters were placed in the middle of the simulated IVC in a horizontal position. The filters80
were assessed in two different positions: central and eccentric. The eccentric position wanted to81
represent placement errors or migration of the filter, since sometimes the filter moves82
from its central position after it is released inside the vena. The eccentric position was set83
with the main axis of the filter placed at the maximum angle possible relative to the IVC.84
Clot trapping capacity was assessed by placing clots of various sizes into the flow system and counting85
the number of clots trapped passing through the filter. For each filter, 30 clots of each size were86
introduced at once. The trapped clots were removed between observations and the number of clots87
that passed through were recorded. This process was repeated 20 times for each filter and each size of88
clots, with the filter positioned centered. Furthermore, the Gu¨nther Tulip filter and the Celect filter89
were also positioned in a tilted position, and the same process was repeated 20 times for each clot size90
and each filter. The experiment was repeated a total of 200 times, and a total of 6000 clots were used.91
Pressure drop of the system was also measured using a traceable manometer in order to observe92
the effects of the clots in the pressure equilibrium of the system. The pressure was measured at two93
different points of the system in order to obtain the pressure drop. The first point was positioned 9094
cm upstream from the filter, and the second point was 10 cm downstream from the filter.95
Student’s t-test for independent samples was used to evaluate differences between filtration capacities96
of each filter.97
2.4 Numerical validation98
Two numerical simulations were carried out to validate the pressure drop measurements taken in vitro.99
Two different geometries were modelled. First, an idealized IVC with a filter inside of the vena and100
then, a IVC with the filter and 8 thrombi attached to it. Since the pressure drop experienced using101
different models of filters did not vary, only the (Gu¨nther Tulip) was used for both simulations. Com-102
putational meshes were created using Ansys Icem (Ansys Inc. Software, Canonsburg, PA, USA) and103
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the numerical CFD simulations were carried out using Ansys CFX (Ansys Inc. Software, Canonsburg,104
PA, USA). See Figure 4 for details on the numerical simulation.105
3 Results106
3.1 Particle size distribution107
Descriptive Statistics have been used to present a quantitative description of the main features of the108
data set (see Table 1). When analyzing the size distribution of small clots (Figure 3 b), the mean,109
median and mode are equal to 3.2 mm. The three values are the same and coincide with the peak of110
the histogram of Figure 3 b, which means that the data follow a normal distribution. The standard111
deviation is 0.26, which indicates that the data are concentrated around the mean and that the112
diameter is less variable. The histogram for small clots is bell-shaped, following a normal distribution,113
in agreement with the observations made from the central tendency values recorded. The histogram is114
symmetrical, the same amount of data falls on both sides of the mean and has skewness (the measure115
of the asymmetry of a histogram) of 0. The histogram has a tall and narrow shape as a consequence116
of the low standard deviation.117
The results of the analysis for large clots are a little bit different. The mean and median are equal118
to 6.4, but the mode has a greater value of 6.9. The histogram is not as symmetric as for small clots119
but it still follows a tendency similar to a normal distribution, as it is observed in Figure 3 c. The120
standard deviation for large clots is 0.5 which is larger to the one obtained for small clots. The121
data is more spread out around the mean and the histogram has a wider shape, as a consequence of122
the higher standard deviation.123
3.2 Filtering efficiency. Clot-Trapping Capacity124
The modified Gu¨nther Tulip filter had the lowest clot capture efficiency, as it may be expected (Table125
2 and Figure 5a and b). The results show that this filter cannot be used to prevent PE because there126
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is a huge percentage of thrombi (almost 80% of big clots and 94.5% of small clots) that127
pass through the filter, meaning that pulmonary embolism is more likely to occur if this128
filter is used.129
The most effective filter was the Gu¨nther Tulip filter in all cases, as shown in Table 2. For large clots,130
its effectiveness is almost 100% and it is barely reduced when the filter is set in a tilted position. For131
smaller clots, its effectiveness is reduced by about 11% when the filter is tilted. Filter 3 also shows132
good results when trapping large clots but its effectiveness trapping small clots is not as good and is133
reduced by 20% when the filter is tilted.134
Statistical evaluation was performed using Student’s t-test (see Table 2) to evaluate differences135
between filtration capacities (α ≤ 0.05). The results showed that the filtering efficiency of both Gu¨nther136
Tulip and Celect filters over the modified Gu¨nther Tulip were higher (p < 0.001). No significant137
statistical differences were observed between the Gu¨nther Tulip and Celect filters when small and138
large clots were inserted in the system in an eccentric position. On the other hand, when small clots139
were used in a tilted position, it was demonstrated that the Gu¨nther Tulip filter is significantly more140
efficient than the Celect filter (p = 0.01).141
All filters showed higher capture rates for large thrombi compared with small thrombi. Differences142
were more significant when the filters were tilted since the effectiveness of the device for large clots143
remained constant while it was reduced for smaller clots. Overall, looking at the results, the most144
efficient filter in terms of clot trapping ability seems to be the Gu¨nther Tulip and less efficient145
filter seems to be the modified Gu¨nther Tulip.146
It is observed in Figures 5 that the effect of gravity, as it will be discussed later in this paper, affects147
the results. The modified Gu¨nther Tulip is only able to trap clots that pass exactly through the center148
of the IVC while the clots flowing closer to the wall of the IVC passed more easily since the filter149
does not have secondary struts. When smaller clots are injected in the model, the effectiveness of the150
filter decreases considerably, being able to trap a smaller number of clots. Figure 5 shows the results151
obtained for the three filter models when large and small clots are injected in the model, being the152
filter set in a centered position. It is observed that the efficiency of both filters is excellent thanks153
to the secondary legs. The secondary struts help the filter trap the clots that do not travel directly154
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through the center of the model. When small clots are thrown in the model, Figure 5 and Table 2155
show that the efficiency of all the filters decreases. Most of the clots travelling through the center of156
the model are still trapped but some of them pass more easily through the struts.157
Figure 6 shows the results obtained for the Gu¨nther Tulip and the Celect filters when the filter is158
tilted. If Figure 5 and 6 are compared it can be observed that the volume of large clots captured by159
the filters does not vary. On the other hand, Figure 6c and d and Table 2 show that the efficiency160
of the filters decreases, when small clots are used. 6 mm clots are big enough to not affect the filter161
efficiency when it is tilted meanwhile 3 mm clots that travel directly away from the dependent wall of162
the IVC pass more easily.163
In conclusion, the efficiency of all filters tested decreased as the size of the embolus164
decreased and as the filter is tilted, as it could be expected. The Gu¨nther Tulip filter165
resulted as the most efficient filter.166
167
3.3 Pressures168
The pressure drop barely changed when the filter was inserted with respect to the measurements taken169
with no filter in the system. For both tests there was always a slight increase in pressure upstream.170
Higher pressures were recorded when some clots (6-8) were present in the filter. Subsequently, the effect171
of trapped clots on pressure drop was measured by injecting sequentially 8 clots and recording the172
pressure drop. 6 clots were needed to be trapped before a comparable increase of the pressure occurred.173
All the measurements were repeated 6 times to make sure that the recordings were consistent with174
each other, and the averaged values were reported in Table 3. Prior to injection of clots, the pressure175
drop was almost the same for the model with and without the filter inside. This shows that the176
presence of the filter in the model does not essentially vary the pressure gradient. Besides,177
as stated by Rahbar et al. (2011) and as shown by Leask et al. (2004, 2001); Harlal et al. (2007), the178
disturbances caused by the filters at a Reynolds number of 600 are negligible. The injection of 8 clots179
raised the pressure drop to 4.1 mmHg.180
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The pressure drop was also measured using a flow rate of 3 L/min. Table 3 shows that the increase in181
the flow rate increases considerably the pressure drop between the two points. A lot of studies on182
inferior vena cava filters use a flowrate of 2L/min Katsamouris et al. (1988); Neuerburg183
et al. (1993); Korbin et al. (1994); Qian et al. (1994) but the reason why a flow rate of184
3L/min has also been used is to compare the pressure drops obtained for two different flow185
rates, and to double check the pressure drop measurements. Besides, there is an increase186
in the flow rate of the IVC after Valsava manuever Gindea et al. (1990); Eichenberger187
et al. (1995),so by using a 3L/min flowrate the behaviour of the filter in more adverse188
conditions is represented. All pressure readings in Table 3 are expressed in mmHg. The same189
procedures were repeated for both the Gu¨nther Tulip and the Celect filters and similar results were190
observed, which means that both filter have the same effect in pressure.191
The results obtained in the numerical simulations are in accordance with the in-vitro measurements.192
For the model with the Gu¨nther Tulip filter the pressure drop recorded was 0.5mmHg, which is similar193
to the in-vitro results of 0.6mmHg. For the second model, where 8 thrombi are attached to the filter,194
the pressure drop obtained was 4mmHg, meanwhile the pressure drop measured in vitro was 4mmHg.195
Figure 7 shows the pressure experienced along the model in a plane. It is observed how little the filter196
affects the pressure in the system meanwhile the thrombi cause a sudden decrease in the pressure.197
4 Discussion198
Clot capture rates in our experiment went from 5.5% to 99.5%. It was observed, in general, that the199
efficiency of the filter was reduced when the size of clots was reduced and when the position of the200
filter was tilted. The best-ranked filter is the Gu¨nther Tulip filter,.201
If the results from our experiment are compared to previous work Ferdani et al. (1995); Katsamouris202
et al. (1988); Hammer et al. (1994), the Gu¨nther Tulip and Celect filters performed fairly well. In203
Katsamouris et al. (1988) investigations, 3 filters (Movin-Udin, Amplatz and Gu¨nther basket)204
presented an increase in pressure above 20cmH2O (≃ 15mmHg) when 3 clots were trapped meanwhile205
the other 3 filter models (Simon Nitinol, Kimray-Greemfield and bird’s nest) presented a pressure206
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increase of almost 5cmH2O(≃ 3.7mmHg) when 6 clots were trapped (which is very close to our207
results). The main reason of the differences in the pressure drops between filter models is208
that some of them are designed for high clot-trapping capacity, and for that reason they209
impede flow the most and result in adverse flow conditions Katsamouris et al. (1988).210
Ferdani et al. (1995) studied the difference in pressure by 6 vena cava filters and obtained similar211
results to our investigations, which show that the filters used by them have similar performance in212
terms of flow impedance. If the IVC is collapsed or close to being collapsed, due to a big213
amount of clots trapped around the filter, there is a huge increase in pressure inside214
the vena. Hirsch and Hoak (1996) state that the risk of thrombosis is elevated when215
the obstruction of the vena cava occurs. For that reason, if the filter causes obstruction216
of the vena cava, thrombosis is more likely to occur. Furthermore, Leask et al. (2004)217
also stated that successful treatment of thrombosis requires the filter to provide high218
filter efficiency without impeding the blood flow, in order to prevent from thrombosis.219
To conclude, the filters that result in a great increase of pressure after clot entrapment,220
will have the highest potential for IVC thrombosis.221
In vitro models have limitations that may raise questions about the clinical relevance of experimental222
studies. The tubing used in our model to represent the IVC was rigid. The deformations223
of the IVC were not taken into account, but respiratory variation and Valsalva result in224
profound changes in the diameter of the IVC Murphy et al. (2008). Different results may225
be obtained if these deformations are considered.226
A second model limitation was the effect of gravity on flowing blood clots, and the influence of this227
effect on clot-trapping capacity of each filter. As blood flow velocity is highest in the center of the228
IVC, emboli are believed to be carried along the center of the blood stream Qian et al. (1994). As229
shown by Lorch et al. (2002); Katsamouris et al. (1988); Robinson et al. (2013), clot capture rates were230
significantly higher with the device in the vertical position. In this report, tests were only performed231
in a stable horizontal position similar to that in supine patients. As a result of gravity, clots failed to232
remain in the center of the fluid column in the phantom and sometimes had a tendency to flow along233
the dependent wall of the IVC and passed more easily through the filter struts. So the effect of gravity234
decreases the clot capture rates when the experiment is performed in the horizontal position.235
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When testing the filter in a tilted position, the devices were pushed into as much tilt as the model236
would allow so the effect of the tilt in the effectiveness of the filter was studied in a worst scenario237
case. When looking at the results obtained with the filters in a tilted position, this considerations has238
to be taken into account.239
The clot size which leads to clinically significant pulmonary embolism remains unclear and dependent240
on factors such as former pulmonary embolization and pre-existing lung disease Lorch241
et al. (2002). The sizes used for this experiment are similar to the diameters used by Lorch et al.242
(2002); Katsamouris et al. (1988); Xian et al. (1995). In our opinion, in cases where only capture243
of large emboli is necessary, such as in young patients with a healthy lung, the Celect filter can be244
recommended. On the other hand, if PE has to be prevented in patients with impaired pulmonary245
function or in a poor general condition who may not be able to tolerate even small emboli, the insertion246
of a more efficient filter such as the Gu¨nther Tulip could be recommended.247
An IVC filter cannot be chosen only on the basis of this experiment. Other factors such as ease248
of placement and documented clinical results must be taken into account. In vitro models are an249
important tool to evaluate the characteristics and performance of different filter models but they are250
limited and cannot reflect filter performances under the in vivo conditions in all aspects. However, in251
vitro testing help us to eliminate the most deficient models and understand how filters work inside the252
body. We realize that the method used to evaluate the efficiency of the filter simulates the worst case253
scenario leading to vena cava occlusion when using large clots. There are many different possibilities254
that can be studied when studying filtering efficiency, but we considered that studying the worst case255
scenario could be a good option to evaluate the efficiency of filters.256
To obtain clinically relevant results a more complex model should be done. Our model257
is a simplified in vitro IVC model, but we can observe the efficiency of the filter models258
used, being the Gu¨nther Tulip the most efficient of them. We can also conclude that the259
pressure through the system only increases significantly for the Celect and Gu¨nther Tulip260
when most of the space inside the vena is collapsed by clots. Neuerburg et al. (1993)261
studied the performance of the Gu¨nther Tulip in vivo. It was observed that the filter262
showed a good hemodynamic behavior in the flow circuit. Besides, the in vivo fatigue263
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testing of the filter revealed a high mechanical testing and the filter demonstrated a264
good biocompatibility with complete endothelization of the wires being in contact with265
the caval wall. This in vivo finding along with our in vitro results demonstrate that the266
Gu¨nther Tulip is very good option to be used in patients.267
Clinical observation studies as the ones performed by Neuerburg et al. (1993); Ferris268
et al. (1993); Athanasoulis et al. (2000) together with valid in vitro investigations are269
important steps on the way to design an ideal vena cava filter. Clinical observations270
reveal important aspects about the filters such as penetration of the wall, migration of271
the filter, and ease of placement but in vitro models allow to do very complete studies272
on filter efficiency.273
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(a) (b)
Fig. 1. Experimental set up: 1. Top-up, 2. Reservoir A, 3. Pressure tabs , 4. Traceable manometer,
5.IVC system, 8. Video recorder, 7. Reservoir B
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(a) (b) (c)
Fig. 2. IVC filters used for the experiment: (a) Modified Gu¨nther Tulip filter, (b) Gu¨nther Tulip filter,
(c) Celect filter. They are low profile, asymmetric, retrievable, made of a cobalt-chromium alloy filters
Cook (2014) that are manufactured by Cook Medical (Bloomington, IN). The design of the Celect
follows that of the Gu¨nther Tulip filter. Both of them have a half-basket shape with a length of 45
mm and a maximum diameter of 30 mm Cook (2014) and have a retrieval hook at the appex to allow
percutaneous retrieval or repositioning De Gregorio et al. (2003).
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Fig. 3. (a) Clots prepared for the experiment. left: small clots range from 65.45mm3 to 220.9mm3
(2.5 mm to 4 mm diameter clots), right: large clots range from 8.2mm3 to 33.51mm3 (5
mm to 7.5 mm diameter clots). (b) frequency histograms of the sample clots, used to estimate
the probability distribution of the feret’s diameter variable
19
(a) (b)
Fig. 4. Finite element mesh of the Gu¨nther Tulip filter (a) without thrombi and (b) with some thrombi.
The two different geometrical models were built using the commercial software SolidWorks (Dessault,
SolidWorks Corp., France). Then, Ansys Icem (Ansys Inc. Software, Canonsburg, PA, USA) was used
to obtain the numerical grids. In order to guarantee that the numerical results were grid independent,
a mesh independence study was carried out prior to the presented simulations. Velocity profiles at
different locations of the IVC model were compared for different grid sizes, concluding that meshes
finer than 4 ∗ 106 for the model with the clots and 1 ∗ 106 for the model with the filter increased the
computational time without adding precision to the solution. The fluid grids were imported in the
commercial package Ansys CFX (Ansys Inc. Software, Canonsburg, PA, USA) were the fluid dynamics
computations were carried out. The numerical approach used by this software is extensively explained
in literature and given in details in CFX (2012). The fluid was assumed Newtonian, incompressible
under steady conditions, laminar and had the same density and viscosity that was used in the exper-
imental study. As boundary conditions, a steady parabolic flow profile with a total volume flow rate
of 2L/min was imposed at both inlet and outlet of the IVC to match the experimental set-up and
no-slip boundary conditions were applied at the wall, filter and clots. The convergence tolerance for
both models was set to 10−8, and the number of iterations was set to 500.
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(a) Modified Gu¨nther Tulip with
large clots trapped
(b) Modified Gu¨nther Tulip with
small clots trapped
(c) Gu¨nther Tulip with large clots (d) Celect with large clots
(e) Gu¨nther Tulip with small clots (f) Celect with small clots
Fig. 5. Small and large clots trapped by the modified Gu¨nther Tulip, Gu¨nther Tulip and Celect filters
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(a) Gu¨nther Tulip with large clots (b) Celect with large clots
(c) Gu¨nther Tulip with small clots (d) Celect with small clots
Fig. 6. Small and large clots trapped by the Gu¨nther Tulip and Celect filters in a tilted postion
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(a) (b)
Fig. 7. Pressure along the numerical model
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small clots large clots
Mean 3.2 6.4
Mode 3.2 6.9
Median 3.2 6.4
STD 0.26 0.5
Clots used 1200 1200
Min.size (mm) 2.5 5
Max.size (mm) 4 7.5
Table 1
Descriptive analysis for clot samples. Measures of central tendency (mean, median, mode) and mea-
sures of variability of dispersion (standard deviation, maximum, minimum)
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Filter Centered position Tilted position
small clots large clots small clots large clots
Modified Gu¨nther Tulip 5.5 21.2 - -
Gu¨nther Tulip 81.7∗ 99.5∗ 69.3† 99
Celect 78.5∗ 98.8∗ 57.8 99.3
Table 2
Percentage of clots (%) captured by each filter in a centered and tilted position. (∗ P<0.001 using
t-test, when compared with Filter 1 and † P<0.01 using t-test, when compared with Celect filter)
25
Filter without filter with filter (2L/min) with 6 clots (3L/min) with 6 clots
Gu¨nther Tulip 0.6 0.6 6.4 4.1
Celect 0.6 0.6 6.4 4.2
Table 3
Measured pressure drop experienced by 2 vena cava filters (mm Hg)
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